• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Generic Company





This company is awful. It hires big pharma rejects and places them in positions of power. These insecure individuals get rid of any person that comes along who has talent and a brain the minute they feel threatened. DO NOT COME HERE unless you are going to be a department head.